Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

231 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase II trial of sequential chemotherapy followed by chemoradiation, surgery, and postoperative chemotherapy for the treatment of stage IIIA/IIIB non-small-cell lung cancer.
Lam P, Berman S, Thurer R, Ashiku S, DeCamp M, Goldstein M, Schumer S, Halmos B, Karp D, Coute D, Bergman M, Boyd-Sirard C, Ou SH, Muzikansky A, Woodard C, Huberman M. Lam P, et al. Among authors: halmos b. Clin Lung Cancer. 2006 Sep;8(2):122-9. doi: 10.3816/CLC.2006.n.040. Clin Lung Cancer. 2006. PMID: 17026813 Clinical Trial.
Molecular testing in lung cancer: the time is now.
Cheng H, Xu X, Costa DB, Powell CA, Halmos B. Cheng H, et al. Among authors: halmos b. Curr Oncol Rep. 2010 Sep;12(5):335-48. doi: 10.1007/s11912-010-0118-z. Curr Oncol Rep. 2010. PMID: 20623207 Review.
Frequent downregulation of the transcription factor Foxa2 in lung cancer through epigenetic silencing.
Basseres DS, D'Alò F, Yeap BY, Löwenberg EC, Gonzalez DA, Yasuda H, Dayaram T, Kocher ON, Godleski JJ, Richards WG, Meyerson M, Kobayashi S, Tenen DG, Halmos B, Costa DB. Basseres DS, et al. Among authors: halmos b. Lung Cancer. 2012 Jul;77(1):31-7. doi: 10.1016/j.lungcan.2012.01.011. Epub 2012 Feb 16. Lung Cancer. 2012. PMID: 22341411 Free PMC article.
A randomized, phase 2 trial of Docetaxel with or without PX-866, an irreversible oral phosphatidylinositol 3-kinase inhibitor, in patients with relapsed or metastatic non-small-cell lung cancer.
Levy B, Spira A, Becker D, Evans T, Schnadig I, Camidge DR, Bauman JE, Hausman D, Walker L, Nemunaitis J, Rudin CM, Halmos B, Bowles DW. Levy B, et al. Among authors: halmos b. J Thorac Oncol. 2014 Jul;9(7):1031-1035. doi: 10.1097/JTO.0000000000000183. J Thorac Oncol. 2014. PMID: 24926548 Free article. Clinical Trial.
231 results